Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ARMS2, ALA69SER

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Genetic factors associated with response to as-needed aflibercept therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
In the present study, we investigated the association between susceptible genetic variants to age-related macular degeneration… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
2020
2020
Association of CRP levels with ARMS2 and CFH variants in age-related macular degeneration
To investigate whether plasma high sensitivity C-reactive protein (hs-CRP) level is associated with exudative age-related macular… Expand
  • table 2
  • figure 1
  • figure 2
  • figure 3
  • table 3
2019
2019
Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration
We investigated the clinical and genetic characteristics of patients with unilateral exudative age-related macular degeneration… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2018
2018
Pachychoroid Geographic Atrophy: Clinical and Genetic Characteristics.
PURPOSE To describe the clinical and genetic characteristics of pachychoroid geographic atrophy (GA) and to compare them with… Expand
2017
2017
Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy
Photodynamic therapy (PDT) combined with intravitreal anti-vascular endothelial growth factor (VEGF) agents is currently the… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
2017
2017
Retreatment of Exudative Age-Related Macular Degeneration after Loading 3-Monthly Intravitreal Ranibizumab
Purpose: The aim of this study was to investigate the clinical implications of required retreatment after 3-monthly intravitreal… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2016
2016
GENETIC FACTORS ASSOCIATED WITH CHOROIDAL VASCULAR HYPERPERMEABILITY AND SUBFOVEAL CHOROIDAL THICKNESS IN POLYPOIDAL CHOROIDAL VASCULOPATHY
Purpose: To investigate genetic factors associated with choroidal vascular hyperpermeability (CVH) and subfoveal choroidal… Expand
2014
2014
Genetic Variants in the SKIV2L Gene in Exudative Age-related Macular Degeneration in the Japanese Population
Abstract Background: To investigate whether genetic variant in superkiller viralicidic activity 2-like (SKIV2L) gene is… Expand
2011
2011
Role of complement factor H I62V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy.
PURPOSE To investigate the role of complement factor H (CFH) I62V (rs800292) and age-related maculopathy susceptibility 2 (ARMS2… Expand
2011
2011
Difference between age-related macular degeneration and polypoidal choroidal vasculopathy in the hereditary contribution of the A69S variant of the age-related maculopathy susceptibility 2 gene…
Purpose To investigate whether the A69S variant of the age-related maculopathy susceptibility 2 gene (ARMS2) has a different… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE